Study Aiming To Predict Cardiac Risk in Breast Cancer Patients Supported by Florida Breast Cancer Foundation Grant
Thanks to modern chemotherapy, gene-targeted therapy, and radiation therapy, there are now over 3.5 million breast cancer survivors in the United States. Each of these treatments, however, may carry an increased risk for major cardiac events and early cardiac death.
Fortunately, University of Florida single-institution data indicate that declines in heart function during treatment can be detected through advanced analysis of heart function based on 3D magnetic resonance imaging (MRI).
The Florida Breast Cancer Foundation has awarded a $99,450 grant to a team led by Walter O’Dell, Ph.D. and Karen Dailey, DO (Co-Principal Investigators), along with co-Investigators Ellen Keeley, MD; Paul Okunieff, MD; Coy Heldermon, MD, Ph.D. and Julie Bradley, MD, who will investigate the application of cardiac magnetic resonance imaging for early detection of cancer-treatment-induced heart injury and the prediction of cardiac risk early during treatment.
Learn more about Study Aiming To Predict Cardiac Risk in Breast Cancer Patients Supported by Florida Breast Cancer Foundation Grant.